«Up-Regulation

Below is an extended Up-Regulation patents listing. Click here to return to the Up-Regulation main in depth entry.

Patents :
US Patent No.	Title
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7408032	PRO1188 polypeptides
7408033	PRO5995 polypeptides
7408034	PRO20025 polypeptides
7408035	PRO9864 polypeptides
7408036	Human voltage gated sodium channel .beta.1A subunit and methods of use
7408042	Anti-PRO6181 antibodies
7410643	Materials and methods relating to fusion proteins for inducing an immune response
7410994	Indole derivatives as anti-inflammatory agents
7411037	Polypeptides encoded by a nucleic acid underexpressed in melanoma
7411040	PRO6182 polypeptides
7407936	Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy
7407929	Leptin peptide antagonists
7407792	Compositions, organisms and methodologies employing a novel human kinase
7405233	Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
7405268	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405269	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7405286	Stars--A muscle-specific actin-binding protein
7405345	Plant seed specific promoters
7406384	System and method for identifying networks or ternary relationships in complex data systems
7407753	Methods, kits and pharmaceutical compositions for diagnosing, delaying onset of, preventing and/or treating osteoporosis
7407763	Systems and methods for detecting and regulating metastasis
7407776	Engineered zinc finger proteins for regulation of gene expression
7407787	Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof
7411047	PRO6097 antibodies
7411051	Antibodies to HDPPA04 polypeptide
7416877	Receptor that causes cell death and recombinant production thereof
7416884	Bioreactor and methods for tissue growth and conditioning
7416888	Cell lines
7417023	Targeted delivery of bioaffecting compounds for the treatment of cancer
7417058	Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
7417115	PRO6027 polypeptides
7417116	PRO7155 polypeptides
7417123	PRO4399 Antibodies
7417125	Antibodies that bind a PRO1158 polypeptide
7417152	4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B.sub.1 receptor antagonists for the treatment of inflammatory diseases
7416872	Taxoid oxygenases and their uses
7416849	HBM variants that modulate bone mass and lipid levels
7416731	Human hairless antibodies
7411057	Nucleic acids encoding human monoclonal antibodies to CTLA-4
7411118	Inbred corn line PHB00
7412332	Method for analyzing polysaccharides
7412333	Method for prognostic factor analysis regarding cancers
7413853	Modulation of metabolism of steroids and xenobiotics
7413869	Method for determining potency of antigenic presenting cell based vaccines
7413895	DNA encoding neutral amino acid transporter
7415358	Molecular toxicology modeling
7415359	Methods and systems for the identification of components of mammalian biochemical networks as targets for therapeutic agents
7416724	Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
7418374	Treatment protocol generation for diseases related to angiogenesis

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.